Antibiotic Resistance of Uropathogenic Pseudomonas Aeruginosa

Susceptibility of multi-drug resistant isolates of <i>Pseudomonas aeruginosa</i> to ceftazidime/aviabactam and ceftolozane/tazobactam in Benha University Hospital in Egypt and de

<i>In silico</i> and Microbiological studies for reduction of <i>Pseudomonas aeruginosa</i> virulence factors controlled by quorum sensing.

IN VITRO ACTIVITIES OF POLYMYXINS GROUP COMBINED WITH IMIPENEM OR MEROPENEM AGAINST CARBAPENEM-RESISTANT PSEUDOMONAS AERUGINOSA

Ceftolozane-tazobactam, ceftazidime-avibactam and ceftazidime-avibactam plus aztreonam combination: Upcoming hope for hospital-acquired MDR/XDR <i>Pseudomonas aeruginosa</i> infe

<i>In vitro</i> activity of ceftazidime-avibactam in combination with aztreonam against carbapenem resistant <i>Enterobacterales</i> isolated from intensive care units

Combatting antimicrobial resistance: Mechanisms, emerging therapies, and future directions

COMBINATION OF CIPROFLOXACIN AND SILVER NANOPARTICLES FOR TREATMENT OF MULTI-DRUG RESISTANT PSEUDOMONAS AERUGINOSA IN EGYPT

Evaluation of In vitro Activity of Cefiderocol and Ceftolozane-Tazobactam against Extended-Spectrum β-Lactamase–Producing Coliform and Multidrug Resistant Acinetobacter baumannii

Testing of antibiotic combinations in <i>NDM-1-</i>producing nosocomial carbapenem resistant <i>Acinetobacter baumannii</i>